Blue Horseshoe Stocks: ICLD, XGTI Recaps & More

InterCloud Systems, Inc. ICLD

ICLD stood out as a solid mover from yesterday’s premarket report. From a morning low of 3.01, the stock made an authoritative move on up to a high of 4.30 just prior to the closing bell.  That represents an increase of 43% on heavy volume to the tune of nearly 38X the three-month average. That figure has been extended to 46%  in the premarket today with the stock touching a high of 4.40 so far.

We’ll want to monitor ICLD for a sustained run; if it can manage higher highs and higher lows today, it would mark the third straight session. The boost it received yesterday was due, in part, to the announcement of a new product launch, the link to which we’ve included below.

InterCloud Systems Announces the Launching of NFVGrid, a Network Functions Virtualization Orchestration Platform (Mon, May 4)


xG Technology, Inc. XGTI

XGTI was another stock from yesterday’s report that made a significant move on the day. It saw a an early low of .40, and would go on to run toward the end of the session, hitting a high of .5474. That worked out to an intraday move of 37%

The stock managed to hold .54 into the close, and the performance came on volume exceeding the monthly average by more than 6X. Anytime we observe action of this kind, we want to be on the lookout for continued activity in subsequent sessions. Already in early trading today we’re seeing the beginnings of a dip-and-rip pattern. We’ll keep our eyes peeled for added chances to take advantage of this play.


OSL Holdings, Inc. OSLH

We tracked OSLH throughout the month of April, and we’re highly rewarded for our vigilance. Between April 2nd (Low: .0021) and April 15th (High: .0274) we witnessed an amazing 1294% run.

Toward the end of last week, OSLH found a bottom after pulling back off of that historic move, and began to rebound from the .0075-mark, and has definitely won back our attention. Yesterday’s session carried OSLH as high as .0144, a 92% swing. We’ll watch this play for the possibility of a protracted rebound off of Friday’s low.


PlasmaTech Biopharmaceuticals, Inc. PTBI

We pulled up PTBI on a routine scan today, and it’s a stock that has been invested in by activist investor George Soros, as we’ve learned in the PR out this morning.. Occasionally, we like to watch stocks that are in the portfolios of high-profile investors. Just last month we followed VLTC over a huge run that was fueled by the involvement of Carl Icahn.

The stock is already up significantly in early trading, and there’s a chance we could see a major gap on the chart up to the 5.50 area filled, so we’ll have this one on our radar for just such an event. We’ve pointed this out below; if PTBI can gain support at or above the 4.40-mark, we like its chances of making a nice run.


Extended Watchlist:
PBR, EFOI, BLRX, EXXI, DENN, JAH

Blue Horseshoe Stocks: ODP Update, FRO & More

Frontline, Ltd. FRO

The last time we mentioned FRO was early this month, at which time the stock was trading at a low of 1.33. It has been ramping its way up over the past few sessions, making higher highs and higher lows, and we wanted to flag it once again this morning as it is trading up significantly in the premarket.

This morning’s high of 2.15 represents an increase of 61% over the 1.33-low that we observed as recently as Monday. With the heavy early-morning momentum we’re seeing we’ll want to follow along with this play closely today and into next week.



Talisman Energy, Inc. TLM

We’ll keep an eye on TLM today as well based on some heavy premarket activity and the fact that the stock is coming up off of its 52-week lows. We’ve noticed a break on the chart due to a gapdown from around 5.60 to 4.80, and with the stock currently trading in the 4.40’s, we should be on the lookout for it to possibly make a run at filling that gap.


ChemoCentryx, Inc. CCXI

Also popping up on our morning scan is CCXI, which is currently trading feverishly in the premarket on the heels of a PR early this morning regarding positive top line results on one of its products currently in testing.

With the stock up over 100% in early trading, we’re going to be on the lookout for massive profit-taking to potentially drive the price back down where it may set us up to take advantage of a dip-and-rip opportunity.

MOUNTAIN VIEW, Calif., Dec. 12, 2014 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (CCXI), a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and cancer, today announced positive top-line 52-week data from its Phase II clinical trial in diabetic nephropathy with CCX140, an inhibitor of the chemokine receptor known as CCR2. >> FULL PR


Office Depot, Inc. ODP

ODP was a good call for yesterday’s session, as it made a solid 8% move on news that a large activist investor took up a significant position in Office Depot while raising its existing stake in Staple stock to 10% total ownership. It is fueling speculation that there could be pressure for a merger between the two, so this is definitely a story we’ll continuously track going forward.


Extended Watchlist:
ONVO, ONTY, DENN, FCEL, UBIQ